An overview of the key trends shaping the pharmaceutical industry today, and those that are set to play a central role in the future, as companies transition towards a new business model: Pharma 2.0.
Provides key strategies and trends shaping the future of the pharmaceutical industry. Examines the impact of the Obama administration on US healthcare, and the implications for Pharma. Assesses the implications of the current economic and financial situation on healthcare. Analyzes key growth drivers and resistors set to shape Pharma\'s future.
Contact me at sosur@datamonitor.com to learn more!
Future Pharma Trends - Long-term opportunities tempered by short-term challenges
1. www.datamonitor.com
Datamonitor America
245 Fifth Avenue
4th Floor
New York, NY 10016
USA
t: +1 212 686 7400
f: +1 646 365 3362
e: usinfo@datamonitor.com
Datamonitor Europe
Charles House
108-110 Finchley Road
London NW3 5JJ
United Kingdom
t: +44 20 7675 7000
f: +44 20 7675 7500
e: eurinfo@datamonitor.com
Datamonitor Asia Pacific
Level 46 / 2 Park Street
Sydney
NSW 2000
Australia
t: +61 2 8705 6900
f: +61 2 8705 6901
e: apinfo@datamonitor.com
Datamonitor Japan
Da Vinci Ginza East 7th Floor
5-14-5 Ginza
Chuo-ku
Tokyo 104-0061
Japan
t: +81 3 5148 7670
f: +81 3 4496 4316
e: jpinfo@datamonitor.com
Future Pharmaceutical
Industry Trends
Long-term opportunities tempered by short-term
challenges
In recent years, Pharma has begun to adapt its business model in response to growing
industry constraints and the decline of the primary-care focused blockbuster therapy. This
process of change has recently been disrupted by unprecedented challenges caused by the
global economic downturn, and by President Obama’s planned overhaul of the US healthcare
system.
To continue on its journey towards Pharma 2.0, Pharma needs to balance the more pressing
short-term issues against the longer-term trends shaping the industry.
Reference Code: DMHC2497
Publication Date: 03/2009